The Spanish Society of Medicinal Chemistry: Promoting Pharmaceutical R&D in Spain since 1977
ChemMedChem · 2024
DOI: 10.1002/cmdc.202400511 ↗Kurz gefasst
Historischer Beitrag in der Zeitschrift ChemMedChem, 2024. Verfasst von José-Manuel Bartolomé-Nebreda und 3 weiteren Autor:innen. Beteiligte Einrichtung: Global Discovery Chemistry, Janssen Research & Development Janssen-Cilag S.A., Jarama 75 A, 45007, Toledo, Spain. Hauptthemen laut MEDLINE: Chemistry, Pharmaceutical. Die Arbeit nennt 11 Literaturangaben.
Abstract (Originalsprache)
The Spanish Society of Medicinal Chemistry (Sociedad Española de Química Terapéutica SEQT), founded in 1977, aims to advance pharmaceutical research and education in Spain, collaborating with academia, industry, and public entities. It was initially linked with the Institute of Medicinal Chemistry from Spanish National Research Council (IQM‐CSIC), emphasizing the independence of medicinal chemistry as a discipline. SEQT′s presidency rotates between representatives from universities, research institutes, and industry, ensuring diverse perspectives. With around 500 members, SEQT represents sectors including universities, CSIC, and industry, with a notable presence of early‐career researchers. The Society actively participates in the European Federation for Medicinal chemistry and Chemical biology (EFMC). SEQT organizes conferences, summer schools, and mini symposia to facilitate networking and knowledge exchange among professionals. To support early‐career scientists, SEQT organizes symposia and awards, recognizing achievements in drug discovery. It fosters mentorship opportunities and engages with international networks like EFMC‐YSN. In 2023, SEQT established its Early Career Scientist (SEQT‐ECS) group to provide tailored support and resources. With over 40 years of experience, SEQT continues to evolve, embracing social media and adapting to changes in medicinal chemistry and chemical biology. It remains committed to supporting its members and advancing research to address human health challenges.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Global Discovery Chemistry, Janssen Research & Development Janssen-Cilag S.A., Jarama 75 A, 45007, Toledo, Spain.
- Departamento de Química y Bioquímica, Facultad de Farmacia, Universidad San Pablo CEU. CEU Universities, 28668, Madrid, Spain.
- Instituto de Química Médica (IQM-CSIC), Juan de La Cierva 3, 28006, Madrid, Spain.
Zitieren
APA
Bartolomé-Nebreda, J. M., de Pascual-Teresa, B., Gutiérrez-Rodríguez, M., & Martín-Martínez, M. (2024). The Spanish Society of Medicinal Chemistry: Promoting Pharmaceutical R&D in Spain since 1977. ChemMedChem. https://doi.org/10.1002/cmdc.202400511
Vancouver
Bartolomé-Nebreda JM, de Pascual-Teresa B, Gutiérrez-Rodríguez M, Martín-Martínez M. The Spanish Society of Medicinal Chemistry: Promoting Pharmaceutical R&D in Spain since 1977. ChemMedChem. 2024. doi:10.1002/cmdc.202400511
BibTeX
@article{BartolomNebreda2024,
author = {Bartolomé-Nebreda, José-Manuel and de Pascual-Teresa, Beatriz and Gutiérrez-Rodríguez, Marta and Martín-Martínez, Mercedes},
title = {The Spanish Society of Medicinal Chemistry: Promoting Pharmaceutical R&D in Spain since 1977},
journal = {ChemMedChem},
year = {2024},
doi = {10.1002/cmdc.202400511}
}
EUVIMED